Global Expansion Laboratoires Bailleul is internationally growing with 10 subsidiaries and distribution in over 85 countries, now positioned under Giuliani S.p.A. This presents opportunities to cross-sell dermatology, gynecology and family medication products to Giuliani’s global network and leverage their R&D and international expansion capabilities.

Strategic Acquisition Acquisition by Giuliani S.p.A. in 2025 can open joint development of new dermo-cosmetic and pharmaceutical offerings, enabling accelerated R&D, access to broader markets, and enhanced credibility when approaching larger distributors and healthcare providers.

Portfolio Fit Core strengths in dermatology, women's health and family medication align with high-demand segments in cosmetics, skincare therapeutics and over‑the‑counter wellness products, suggesting targeted upsell opportunities to retailers, clinics and pharmacies already familiar with their brands.

SME Scale Advantage With a mid‑sized employee base and revenue in the lower‑hundreds of millions, there is flexibility to tailor regional partnerships, co‑marketing deals and interim pilot programs with Giuliani’s infrastructure to scale efficiently without the complexity of mega‑pharma negotiations.

Partner Growth Utilize existing digital and distribution channels (WordPress, SAP, e‑mail, social and marketplace tools) to accelerate channel partner onboarding, streamline order-to-cash and implement joint marketing campaigns across the 85+ country footprint.